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Properties of thyme extracts from three diﬀerent species (Thymus vulgaris, Thymus zygis, and Thymus hyemalis) were examined.
Two oil fractions from each species were obtained by CO2 supercritical ﬂuid extraction. Main compounds presented in the
supercritical extracts of the three thyme varieties were 1,8 cineole, thymol, camphor, borneol, and carvacrol. As a cellular model
of inﬂammation/atherogenesis, we use human macrophages derived from THP-1 monocytes and activated by oxidized LDLs.
These cells were incubated with the thyme fraction oils, and the productions and gene expressions of the inﬂammatory mediators
TNF-α, IL-1B, IL-6, and IL-10 were determined. Thyme extracts signiﬁcantly reduced production and gene expression of the
proinﬂammatory mediators TNF-α, IL-1B, and IL-6 and highly increased these parameters on the anti-inﬂammatory IL-10
cytokine. Changes on production and gene expressions were dose dependent and according to the thyme content of each species.
Taken together, these results may suggest that thyme extracts could have anti-inﬂammatory eﬀects.
1.Introduction
Cardiovascular disease, the leading cause of death in West-
ern countries, is a preeminent health problem worldwide
[1]. Atherosclerosis, a Chronic Inﬂammatory-Based Disease
(CIBD), constitutes the single most important contributor
for cardiovascular complications [2]. Mainly, atherosclerosis
results from an immune response to oxidized low-density
lipoproteins (LDLs) [3]. Induced by an atherogenic diet,
monocytes are promoted to adhesion into the artherial
endothelium and intimae (diapedesis). Once in the intimae,
monocytesdiﬀerentiateintomacrophagesandthenmodiﬁed
lipoproteins (such as oxidized LDLs) are accumulated as
cytoplasmatic droplets. This process becomes macrophage
into foam cells that characterize the early atherosclerotic
lesion [4]. Macrophages and foam cells produce inﬂamma-
tory mediators responsible for the lesion growth. Some of
these mediators are involved in proatherogenic processes,
such as interleukin- (IL-) 1, IL-6, and Tumor Necrosis
Factor alpha (TNF-α) that involve in the upregulation of
the molecular adhesion on the endothelial cells. Others have
demonstrated to have antiatherogenic properties such as IL-
10 that involve in the attenuation of the monocyte differen-
tiation into macrophages [3].
The use of medicinal plants, or extracts from them, has
been traditionally practiced worldwide in the prevention and
treatment of several chronic diseases such as cardiovascular
diseases, intestinal inﬂammatory diseases, inﬂammatory
bowel disease, arthritis, diabetes, allergies, multiple sclerosis,
Parkinson’s and Alzheimer’s diseases, and others [5]. A
Mediterranean aromatic plant, thyme, has been frequently
used for those purposes. Extracts from thyme have been
used in traditional medicine for the treatment of several
respiratory diseases like asthma and bronchitis [6]a n d
for the treatment of other pathologies thanks to several
properties such as antiseptic, antispasmodic, antitussive
antimicrobial, antifungal, antioxidative, and antiviral [7, 8].
Thyme oils have also been described as a strong bacte-
ricide against Gram-positive and Gram-negative bacteria2 Journal of Obesity
Table 1: Composition of the supercritical extracts of the three thyme varieties obtained in separators 1 and 2, and the contribution of each
compound to the total chromatographic area. N-I: nonidentiﬁed compound; R.I.: linear retention index; n.d.: non detected.
Compound Ret. time (min) R.I.
Thymus hyemalis Thymus zygis Thymus vulgaris
Separator
1
Separator
2
Separator
1
Separator
2
Separator
1
Separator
2
%A r e a %A r e a %A r e a %A r e a %A r e a %A r e a
P-cymene 12.93 1022 2.97 2.77 4.77 2.98 4.90 5.57
1,8 cineole 13.30 1029 20.97 19.39 1.03 n.d. 1.29 0.95
Gamma-terpinene 14.89 1056 0.81 0.67 0.7 0.5 1.14 1.11
Sabinene 15.37 1065 2.52 1.97 n.d. 0.45 1.37 0.92
Linalool 17.39 1099 3.73 1.57 6.30 4.22 6.61 3.72
Camphor 19.74 1140 27.44 19.63 1.47 1.04 1.49 0.83
Borneol 21.03 1163 8.33 8.43 4.71 4.01 3.35 2.60
Alpha-terpineol 22.51 1188 3.96 3.80 0.66 0.82 0.81 0.45
Bornyl acetate 28.18 1282 1.67 1.24 n.d. 0.71 0.81 0.75
Thymol 28.63 1290 10.05 23.01 70.86 75.04 65.43 71.15
Carvacrol 29.21 1299 0.64 1.34 4.20 4.61 4.26 4.30
Isobornyl propionate 34.62 1372 1.21 0.87 n.d. n.d. n.d. n.d.
E-caryophyllene 37.78 1412 4.05 3.04 2.01 1.25 4.51 2.22
N-I 39.63 1433 0.09 n.d. 1.84 2.98 2.63 4.49
Germacrene-D 43.13 1474 1.73 1.26 n.d. n.d. n.d. n.d.
Gamma-elemene 44.52 1490 1.97 1.55 n.d. n.d. n.d. n.d.
Elemol 49.37 1552 1.15 1.46 n.d. n.d. n.d. n.d.
Spathulenol 51.21 1576 2.42 2.85 n.d. n.d. n.d. n.d.
Caryophyllene oxide 51.42 1579 1.34 0.90 1.4 1.04 1.33 0.87
N-II 56.52 1683 2.77 4.15 n.d. 0.28 n.d. n.d.
and also as a bronchospasmolytic [9, 10]. However, too
manylittleisknownaboutthymeanti-inﬂammatoryactivity.
For example, it has been reported that thyme oil reduces
NO production in J774A.1 murine macrophages [11]. The
biological activity of medicinal plants strongly depends
on their composition. Major bioactive compounds of the
extracts from thyme are carvacrol and thymol [12, 13].
Thymol exhibits multiple biological activities including anti-
inﬂammatory [14], immunomodulating [15], antioxidant
[16], antibacterial [17], antifungal [18], and free radical
scavenging properties [19]. Carvacrol also possesses antimi-
crobial,antifungal,andantioxidantactivities[20–22],aswell
as antimutagenic and anticarcinogenic eﬀects [23]. There
have been demonstrated eﬀects on the treatment of colitic
mice with essential oils of thyme and oregano containing
thymol and carvacrol as their principal bioactive com-
pounds, decreasing levels of the proinﬂammatory cytokines
IL-1β,I L - 6 ,a n dT N F - α. However, mechanisms mediating
these suppressive eﬀects are unclear [8]. Borneol, another
compound present in thyme, has been also described as an
anti-inﬂammatory since its dietary supplementation signif-
icantly decreases the concentration of the proinﬂammatory
cytokines IL-1β and IL-6 in mice [5].
Nowadays medicinal therapies for CIBDs involve treat-
ment with nonsteroidal anti-inﬂammatory drugs, antibi-
otics, corticosteroids, and immunosuppressant, but the
application of these drugs is limited due to their toxicity and
side eﬀects [24]. Therefore, there is an increasing interest in
ﬁnding alternative treatments with fewer side eﬀects.
Supercritical ﬂuid extraction (SFE) is considered an at-
tractive extraction method when compared to conventional
techniques such as steam distillation or Soxhlet extraction
because it avoids solute contamination with solvent residues
andthedegradationofthermolabilecompounds[25].Inthis
sense, SFE with CO2 is in increasing demand to produce
high-qualityessentialoilsfromplantmaterialwithmedicinal
properties [26].
During our on-going screening program, designed to
identify natural compounds with anti-inﬂammatory poten-
tial, we have studied thyme oils from three diﬀerent species
(Thymus vulgaris, Thymus zygis,a n dThymus hyemalis). To
determinatewhetherthymeoilscouldhaveimmunomodula-
tionpropertiesandcouldmediateininﬂammatorycytokines
regulation, we study the eﬀect of our extracts on ox-LDL-
activatedTHP-1macrophages,measuringtheexpressionand
release of several inﬂammatory mediators.
2. Results and Discussion
CO2 SFE oil fractions composition from three diﬀerent spe-
cies of thyme (Thymus vulgaris, Thymus zygis,a n dThymus
hiemalys) were determined by GC-MS (See Table 1). Main
compounds present were thymol, 1,8-cineole, carvacrol, andJournal of Obesity 3
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Figure 1: Chemical structures of the main compounds present in the supercritical extracts of the three thyme varieties: (a) 1,8 cineole, (b)
thymol, (c) camphor, (d) borneol, and (e) carvacrol.
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Figure 2: Eﬀects of thyme extracts from three diﬀerent species (Thymus vulgaris, Thymus zygis, and Thymus hyemalis), on macrophage-
THP-1 cell viability. Cells were treated with increasing concentrations of thyme extracts, from 0 to 25μg/mL for 24h. Cell viability was
determined by the MTT assay. Values represent the mean ± SEM of six independent experiments. No statistic signiﬁcation in P values lower
than 0.05 was found.
borneol. Chemical structures of these compounds are shown
in Figure 1.
The cytotoxicity eﬀect on THP-1 macrophages of S1
and S2 CO2 supercritical ﬂuid extracts from thyme leaves
was evaluated before the bioactivity study. MTT assay was
performed for periods of 24 of incubation (Figure 2). After
24 hours of incubation neither extracts reduced signiﬁcantly
cell viability for concentrations from 5 to 25μg/mL.
To activate the THP-1 macrophage, Cu2+-oxidized LDLs
(ox-LDL) were added to the incubation medium. These ox-
LDL-treatedcellsshowedanincreaseintotalproteinsecreted
(data not shown). The increase in protein secretion was used
as an indicator for macrophage activation [3]. Treatment
of activated cells with thyme fractions results in an overall
reduction of proinﬂammatory cytokines release, TNFα,I L -
1β, and IL-6 (Figures 3 and 4), in a dose-dependent manner.
To test anti-inﬂammatory eﬀects of oil extracts, one group
was treated with a small amount of diclofenac (5μg/mL). It
wascarriedoutaspositive standardcontrol[27,28].Extracts
in general show a better anti-inﬂammatory eﬀect than
diclofenac at this small concentration, diminishing more
the proinﬂammatory cytokines (TNF-α and IL-1β) than di-
clofenacdidandinducinganti-inﬂammatoryreleaseofIL-10
that was not observed with diclofenac.
After 24 hours of incubation, activated cells treated with
any of the thyme fractions showed a very signiﬁcant decrease
in TNF-α release when compared with nontreated cells. Both
fractions of Thymus zygis and Thymus vulgaris had similar
eﬀects on TNF-α secretion. For fraction concentrations of
15μg/mL and higher, the reduction of TNF-α was such that
these cytokine levels were much lower than the nonactivated
basallevels.ForThymushyemalis,TNF -αsecretionwaslower
than the nonactivated controls for fraction concentrations
of 25μg/mL. Despite the large reduction of TNF-α secretion
at 24 hours treatments, treatment with fractions of Thymus
zygis and Thymus vulgaris for 48 hours showed a lesser
reduction of TNF-α. For these fractions, only concentrations
of 25μg/mL induced a very signiﬁcant reduction of TNF-
α levels, equal to nonactivated basal levels. At 48 hours,
Thymus hyemalis induced larger TNF-α release inhibition,4 Journal of Obesity
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Figure 3: Dose eﬀe c to f5 ,1 5 ,a n d2 5μg/mL of thyme extracts S1 and S2 from three diﬀerent species (Thymus vulgaris, Thymus zygis, and
Thymus hyemalis) on the production and secretion of TNF-α (a), IL-1β (b), IL-6 (c), and IL-10 (d) on macrophage-THP-1 cells. Cells were
diﬀerentiated with (PMA) 100ng/mL for 24h and afterwards treated as described in Section 3 for 24 hours. Data represent means ± SEM
calculated from six independent experiments with 3 replications for each treatment. Statistic Dunnett’s multiple comparison test versus Ctrl
+oxLDL signiﬁcation is represented by ∗P values less than 0.05, signiﬁcant; ∗∗P values less than 0.01, very signiﬁcant; and ∗∗∗P values less
than 0.001, extremely signiﬁcant. One group was treated with a small concentration of diclofenac (5μg/mL) as positive standard control.
Statistic Bonferroni multiple comparison test versus Ctrl −oxLDL signiﬁcation is represented by   P values less than 0.01, very signiﬁcant
and    P values less than 0.001, extremely signiﬁcant. One group was treated with a small concentration of diclofenac (5μg/mL) as positive
standard control.
withallfractionsconcentrationshowingadecreaseunderthe
nonactivated basal levels.
Regarding IL-1β release at 24 hours, treatment of acti-
vated cells with any of the thyme fractions induced a de-
creaseof this cytokine secretion in a dose-dependent manner
(Figure 3(b)). Both fractions of Thymus zygis or Thymus
vulgaris induced similar reduction of IL-1β. 24-hour treat-
ment with 15μg/mL of these fractions reduced IL-1β secre-
tion signiﬁcantly to the nonactivated cells basal secretion.
After 48-hour incubation with these thyme fractions, IL-
1β concentration in the medium was the same as the basal
secretions of nonactivated cells. IL-1β concentration did not
decreasewhenthymefractionconcentrationswereincreased.
Regarding Thymus hyemalis, at 24-hour treatments, both
fractions of this species induced similar cell responses.
T h e r ei sad e c r e a s ei nI L - 1 β secretion with the increase of
fraction concentration, although this IL-1β decrease is only
signiﬁcant till 25μg/mL incubations. After 48 hours, incu-
bations with these two fractions reduced IL-1β secretion to
nonactivatedbasallevelsinthesamemannerasThymuszygis
and Thymus vulgaris did.
IL-6 secretion was reduced signiﬁcantly when activated
cells were incubated with any of the fractions of either
Thymus zygis or Thymus vulgaris at a concentration of
15μg/mL or higher. This reduction on IL-6 secretion was
dose dependent and was veriﬁed on both 24 and 48 hours
of incubations. Incubations with 25μg/mL of these extracts
reduced IL-6 secretion to nonactivated cells basal levels. 48-
hour treatment with Thymus hyemalis, induced the same
decrease as Thymus zygis and Thymus vulgaris, whereas atJournal of Obesity 5
0
50
100
150
C
t
r
l
 
+
 
o
x
L
D
L
C
t
r
l
−
o
x
L
D
L
o
x
L
D
L
 
+
 
D
i
c
l
o
f
. 51 5 2 5 51 5 2 5 51 5 2 5 51 5 2 5 51 5 2 5 5 51 5 2 5
T
.
 
z
y
g
i
s
 
S
1
T
.
 
z
y
g
i
s
 
S
2
T
.
 
v
u
l
g
a
r
i
s
 
S
1
T
.
 
v
u
l
g
a
r
i
s
 
S
2
T
.
 
h
y
e
m
a
l
i
s
 
S
1
T
.
 
h
y
e
m
a
l
i
s
 
S
2
♦♦♦
♦♦♦
∗∗∗
∗∗∗
∗∗∗
∗∗∗
∗∗∗
∗∗ ∗∗ ∗∗
∗
♦♦♦
♦
∗∗∗
♦♦♦
∗∗∗
♦♦♦
∗∗∗
♦♦♦
∗
∗
♦♦♦ ♦♦♦
♦♦♦
♦♦ ♦
♦ ∗
T
N
F
-
α
(
1
0
0
%
=
8
8
5
±
9
6
p
g
/
m
L
)
on TNF-α levels
48 h dose eﬀect of thyme extract (μg of extracts)
(a)
0
50
100
150
C
t
r
l
 
+
 
o
x
L
D
L
C
t
r
l
−
o
x
L
D
L
o
x
L
D
L
 
+
 
D
i
c
l
o
f
. 51 5 2 5 51 52 5 51 52 5 51 52 5 51 5 2 5 5 51 5 2 5
T
.
 
z
y
g
i
s
 
S
1
T
.
 
z
y
g
i
s
 
S
2
T
.
 
v
u
l
g
a
r
i
s
 
S
1
T
.
 
v
u
l
g
a
r
i
s
 
S
2
T
.
 
h
y
e
m
a
l
i
s
 
S
1
T
.
 
h
y
e
m
a
l
i
s
 
S
2
on IL-1β levels
I
L
-
1
β
(
1
0
0
%
=
1
0
6
5
±
9
4
p
g
/
m
L
)
♦♦♦
∗∗∗
♦
∗∗∗
♦
∗∗∗
∗∗∗ ∗∗∗
∗∗∗
∗∗∗∗∗∗
∗∗∗∗∗∗
∗∗∗∗∗∗
∗∗∗
∗∗∗∗∗∗
∗∗∗
∗∗∗ ∗∗∗
∗∗∗ ∗∗∗
48 h dose eﬀect of thyme extract (μg of extracts)
(b)
0
50
100
150
C
t
r
l
 
+
 
o
x
L
D
L
C
t
r
l
−
o
x
L
D
L
o
x
L
D
L
 
+
 
D
i
c
l
o
f
. 51 52 5 51 5 2 5 51 5 2 5 51 5 2 5 51 5 2 5 5 51 5 2 5
T
.
 
z
y
g
i
s
 
S
1
T
.
 
z
y
g
i
s
 
S
2
T
.
 
v
u
l
g
a
r
i
s
 
S
1
T
.
 
v
u
l
g
a
r
i
s
 
S
2
T
.
 
h
y
e
m
a
l
i
s
 
S
1
T
.
 
h
y
e
m
a
l
i
s
 
S
2
on IL-6 levels
I
L
-
6
 
(
1
0
0
%
=
1
2
1
0
±
1
7
2
p
g
/
m
L
)
♦♦♦ ♦♦♦ ♦♦♦
♦♦
♦♦
♦
♦
∗∗∗
∗∗∗
∗∗∗
∗∗∗
∗∗∗ ∗∗∗
∗∗∗
∗∗∗
∗∗∗
∗∗∗ ∗∗∗
∗∗∗
∗∗
48 h dose eﬀect of thyme extract (μg of extracts)
(c)
0
100
200
300
400
500
C
t
r
l
 
+
 
o
x
L
D
L
C
t
r
l
−
o
x
L
D
L
D
i
c
l
o
f
e
n
a
c 51 5 2 5 51 5 2 5 51 5 2 5 51 5 2 5 51 5 2 5 5 51 5 2 5
T
.
 
z
y
g
i
s
 
S
1
T
.
 
z
y
g
i
s
 
S
2
T
.
 
v
u
l
g
a
r
i
s
 
S
1
T
.
 
v
u
l
g
a
r
i
s
 
S
2
T
.
 
h
y
e
m
a
l
i
s
 
S
1
T
.
 
h
y
e
m
a
l
i
s
 
S
2
on IL-10 levels
I
L
-
1
0
 
(
%
 
o
f
 
o
x
L
D
L
-
c
t
r
l
.
)
♦♦♦
∗∗∗
♦♦♦
∗∗∗
♦♦♦
∗∗∗ ♦♦♦
∗∗∗
♦♦♦
∗∗∗
♦♦♦
∗∗∗
48 h dose eﬀect of thyme extract (μg of extracts)
(d)
Figure 4: Dose eﬀe c to f5 ,1 5 ,a n d2 5μg/mL of thyme extracts S1 and S2 from three diﬀerent species (Thymus vulgaris, Thymus zygis, and
Thymus hyemalis) on the production and secretion of TNF-α (a), IL-1β (b), IL-6 (c), and IL-10 (d) on macrophage-THP-1 cells. Cells were
diﬀerentiated with (PMA) 100ng/mL for 24h and afterwards treated as described in Section 3 for 48 hours. Data represent means ± SEM
calculated from six independent experiments with 3 replications for each treatment. Statistic Dunnett’s multiple comparison test versus Ctrl
+oxLDL signiﬁcation is represented by ∗P values less than 0.05, signiﬁcant; ∗∗P values less than 0.01, very signiﬁcant; and ∗∗∗P values less
than 0.001, extremely signiﬁcant. One group was treated with a small concentration of diclofenac (5μg/mL) as positive standard control.
Statistic Bonferroni multiple comparison test versus Ctrl −oxLDL signiﬁcation is represented by   P values less than 0.01, very signiﬁcant;
and    P values less than 0.001, extremely signiﬁcant. One group was treated with a small concentration of diclofenac (5μg/mL) as positive
standard control.
24 hours, there was no signiﬁcant reduction of IL-secretion
at the concentrations used.
Thyme had opposite eﬀects on the anti-inﬂammatory
cytokine IL-10. 24-hour treatment with any of the fractions
induced an increase on IL-10 secretion in a dose-dependent
manner; higher fraction concentration induced higher IL-
10 secretion. Again, Thymus zygis and Thymus vulgaris were
more eﬀective than Thymus hyemalis. Thymus zygis and
Thymus vulgaris increased signiﬁcantly IL-10 secretion of
activated cells, with both fractions and at any of the concen-
trations used. As for Thymus hyemalis, the increase in IL-10
secretion was lower and only signiﬁcant when the fractions
were 15μg/mL or higher concentrations. 48-hour treatments
with higher concentrations of the fractions induced an
increase on IL-10 secretion; the rest concentrations did not
induce signiﬁcant increases.
In all experiments, Thymus hyemalis hadshowntobe less
eﬀective than Thymus vulgaris and Thymus zygis, either in
increasing or reducing cytokine release. A dose-dependent
eﬀect was observable in treatments with 24 and 48 hours
of incubation. Changes on production were dose dependen-
tent and according to the thymol content of each species
(Table 1).
Relative quantiﬁcation (RQ) determinates the change in
expressionofanucleicacidsequencerelativetoacontrol.RQ
valuesrepresentedinFigures5and6areequivalenttomRNA6 Journal of Obesity
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Figure 5: Eﬀect of 25μg/mL of thyme extracts S1 and S2 from three diﬀerent species (Thymus vulgaris, Thymus zygis, and Thymus hyemalis)
on the relative quantiﬁcation (RQ) of TNF-α gene expression (a), IL-1β (b), IL-6 (c), and IL-10 (d) on macrophage-THP-1 cells. Cells
were diﬀerentiated with (PMA) 100ng/mL for and afterwards treated as described in Section 3 for 24 hours. Data represent means ± SEM
calculated from six independent experiments with 3 replications for each treatment. Statistic Dunnett’s multiple comparison test versus Ctrl
+oxLDL signiﬁcation is represented by ∗P values less than 0.05, signiﬁcant; ∗∗P values less than 0.01, very signiﬁcant; and ∗∗∗P values less
than0.001,extremelysigniﬁcant.StatisticBonferronimultiplecomparisontestversusCtrl−oxLDLsigniﬁcationisrepresentedby   P values
less than 0.01, very signiﬁcant; and    P values less than 0.001, extremely signiﬁcant. One group was treated with a small concentration of
diclofenac (5μg/mL) as positive standard control.
expression. Endogenous control represented in this ﬁgures
was 18S rRNA; similar results were showed using GAPDH
(data not shown).
Similar to the observed cytokine release, gene expres-
sion of analyzed cytokines, but not IL-10, increased in
oxLDL-activated cells compared with nonactivated cells in
treatments during 24 hours. 48-hour treatments caused an
increase only in TNFα expression on oxLDL-activated cells
compared with nonactivated cells.
TNFα gene expression decreases only in cells treated with
Thymus zygis S1 at 24 hours of incubation; other treatments
didnotchangeexpressionofthisgenewithrespecttooxLDL-
activated cells. Similar to 24 hours of incubation, at 48
hours TNF-α gene expression did not change with extract
treatments; only Thymus hyemalis S2 caused signiﬁcant re-
duction of this cytokine gene expression.
Expression of IL-1β decreased in cells treated with all
thyme extracts with respect to activated cells at 24 hours of
incubation. At 48 hours of incubation, all treatments, except
Thymus hyemalis S2, caused reduction in gene expression.
For Thymus zygis S2, Thymus vulgaris S1, and S2 and Thy-
mus hyemalis S1, expression of IL-1β was lower than the
nonactivated controls cells.
IL-6 gene expression at 24-hour treatment with any of
thyme extracts was reduced until level of nonactivated con-
trol cells which expression was decreased to half compared to
activated cells. In contrast, at 48-hour treatment, expression
was reduced using only Thymus zygis S1 and S2 and Thymus
vulgaris S2 extracts with respect to activated cells.
IL-10 expression gene increased twice with all thyme
extracts at 24 hours of treatment compared with oxLDL-
activated cells. At 48 hours, gene expression in cells treated
withThymus zygis S1 and S2 and Thymus vulgaris S1 extracts
increased signiﬁcantly, but Thymus vulgaris S2 and Thymus
hyemalis did not change expression of IL-10 compared to
oxLDL-activated cells.Journal of Obesity 7
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Figure 6: Eﬀect of 25μg/mL of thyme extracts S1 and S2 from three diﬀerent species (Thymus vulgaris, Thymus zygis, and Thymus hyemalis)
on the relative quantiﬁcation (RQ) of TNF-α gene expression (a), IL-1β (b), IL-6 (c), and IL-10 (d) on macrophage-THP-1 cells. Cells
were diﬀerentiated with (PMA) 100 ng/mL for 24h and afterwards treated as described in Section 3 for 48 hours. Data represent means
± SEM calculated from six independent experiments with 3 replications for each treatment. Statistic Dunnett’s multiple comparison test
versus Ctrl +oxLDL signiﬁcation is represented by ∗P values less than 0.05, signiﬁcant; ∗∗P values less than 0.01, very signiﬁcant; and ∗∗∗P
values less than 0.001, extremely signiﬁcant. Statistic Bonferroni multiple comparison test versus Ctrl −oxLDL signiﬁcation is represented
by   P values less than 0.01, very signiﬁcant; and    P values less than 0.001, extremely signiﬁcant. One group was treated with a small
concentration of diclofenac (5μg/mL) as positive standard control.
Cytokines are considered to be key players in the
inﬂammatory response involved in atherosclerosis and other
Chronic Inﬂammatory-Based Diseases (CIBDs). Among
these, Interleukin (IL)-1β, IL-6, IL-10, and Tumor Necrosis
Factor-α (TNF-α) are expressed in atherosclerotic lesions
by endothelium cells, macrophages, and smooth muscle
cells [29, 30]. Some of them are involved in proatherogenic
processes, such as upregulation of adhesion molecules on
the endothelial cells, while others were proved to have an
antiatherogenic role like attenuating the diﬀerentiation of
monocytes in macrophages. Both IL-1 and IL-6 enhance
the inﬂammatory process. The imbalanced expression of
cytokines has been implicated in the progression of many
diseases including CIBDs [31]. Cytokines exhibit both
beneﬁcial and pathologic eﬀects on their target cells and
are produced by many cell types [32]. Several natural
compounds are known for their beneﬁcial properties to
somediseasesortheirderivedcomplicationsandparticularly
concerning anti-inﬂammatory eﬀects.
In our experiments, were observed signiﬁcant cellular
responseselicitedbythetreatmentofTHP-1cellswiththyme
fractions. The action of thyme fractions appears to involve
the expression of the proinﬂammatory cytokine: TNF-α,
IL-6, and IL-1β and the anti-inﬂammatory cytokine IL-
10. The most interesting observation made during these
studies was that treatment of oxLDL-activated THP-1 cells
with thyme oils had diﬀerent eﬀects on proinﬂammatory
and anti-inﬂammatory expression: TNF-α, IL-6, and IL-
1β expressions were inhibited while IL-10 expression was
enhanced. Proinﬂammatory cytokines levels decreased in
a dose-dependent manner with any thyme fraction from
Thymus vulgaris, Thymus zygis, or Thymus hyemalis used
(after 24 or 48h of incubation). These results were in agree-
ment with the ones regarding the expression of cytokines
genes at 24 hours of incubation. Other authors have
previously reported an increment in cytokine secretion in
activated macrophages treated with ox-LDL [3, 33]. Similar
results have been described for essential oils extracted from8 Journal of Obesity
Cinnamomum osmophloeum, a herb traditionally used in
Asia as food and as a medicine, which contains cinnamalde-
hyde. Murine macrophages were treated with essential oils
from this plant; anti-inﬂammatory eﬀects by decreasing
TNF-α, IL-6, and IL-1β secretions were reported [33].
Main compounds present in supercritical thyme extract
were thymol, 1,8 cineole, camphor, borneol, and carvacrol.
Anti-inﬂammatory eﬀect of thymol has been reported on
human neutrophiles incubated with 10 or 20μg/mL of this
compound [14]. Mice edema has been reported to be re-
duced with a topical application of 100μg/cm2 of carvacrol
[34]. Moreover, antioxidant properties of thymol and car-
vacrol have been demonstrated in several studies, suggesting
their use as nutraceutical ingredients in the development of
novel functional foods. Derivatives of thymol and carvacrol
have been described as antioxidant according to the DPPH
radical scavenging method [35–37]. Essential oils of thyme
and their components carvacrol and thymol inhibited 3-
nitrotyrosine formation, biomarker of the oxidative stress,
supporting the nutraceutical value of thyme and the poten-
tial of thymol and carvacrol in preventing the formation of
toxic products by the action of reactive nitrogen species [36].
Also, thymol and carvacrol prevent autoxidation of lipids
[37].
In the same way, the inhibitory activity of 1,8-cineol
(eucalyptol)oncytokineproductioninculturedhumanlym-
phocytes and monocytes has been described [38]: particu-
larly, in monocytes, inhibition of TNF-α,I L - 1 β,I L - 6 ,a n d
IL-8 was 99, 84, 76, and 65%, respectively, when monocytes
were treated with 0.15μg/mL of 1,8-cineol.
Borneol, one of the major compounds present in essen-
tial oils from sage, has been described as anti-inﬂammatory
since its dietary supplementation signiﬁcantly decreases the
concentration of the proinﬂammatory cytokines IL-1β and
IL-6 in mice [5].
Results observed in this work suggest that supercritical
thyme S1 and S2 fraction oils from Thymus vulgaris, Thymus
zygis, and Thymus hyemalis may act as eﬀective inhibitors
of oxLDL-induced proinﬂammatory cytokines (TNF-α,I L -
1β, and IL-6) secretion, and also as enhancers of the anti-
inﬂammatorycytokineIL-10secretion,inmacrophageTHP-
1cells.Insummary,CO2 supercriticalthymeextractsshowed
anti-inﬂammatory properties by (a) reducing the release of
proinﬂammatory cytokines, and (b) increasing the anti-
inﬂammatory secretion in activated macrophages. These re-
sults may suggest that essential oils from thyme extracts
could be used as novel options for treatment of chronic dis-
eases based on inﬂammatory processes. However, numerous
and in-depth studies should be carried out for this purpose.
3.ExperimentalSection
3.1. Plant Materials and Preparation of the CO2 Supercritical
Fluid Extraction Fraction
3.1.1. Extraction of Plant Material. Dried and cryogenic
grinded leaves from three varieties of thymes (Thymus
hyemalis, Thymus zygis, and Thymus vulgaris)w e r es u b j e c t e d
to supercritical ﬂuid extraction with CO2. The supercritical
extractions were carried out in a pilot-plant-scale supercrit-
ical ﬂuid extractor (Thar Technology, Pittsburgh, PA, USA,
model SF2000) of 2L capacity using pure supercritical CO2
at a pressure of 300 bar and a temperature of 40◦C. Extracts
from the three thyme species were fractionated using a two-
cascade depressurized system and samples were collected in
eachofthetwo(separators1and2)separators.Fractionation
conditions were as follows: separator 1 was kept at constant
pressure and temperature of 15MPa and 40◦C, respectively,
whereas separator 2 was maintained at a pressure of 2MPa
and a temperature of 40◦C.
3.1.2. GC-MS Analysis. Composition of the supercritical
thyme extracts was carried out by a GC-2010 (Shimadzu,
Japan), equipped with a split/splitless injector, electronic
pressurecontrol,AOC-20iautoinjector,GCMS-QP2010Plus
mass spectrometer detector, and a GCMS Solution software.
The column used was a ZB-5 (Zebron) capillary column,
30m × 0.32mm I.D, and 0.25μm phase thickness. Helium,
99.996%, was used as a carrier gas at a ﬂow of 1mL/min.
Oven temperature programming was 60◦C isothermal for
4min, increased to 64◦Ca t1 ◦C/min, and then increased to
106◦Ca t2 . 5 ◦C/min. Oven temperature was then increased
from 106◦C to 130◦Ca t1 ◦C/min, then to 200◦Ca t5 ◦C/min,
and then to a ﬁnal temperature of 250◦C/min at 8◦C/min
which was kept constant for 10min. Sample injections (1μL)
were performed in split mode (1:20). The inlet pressure of
the carrier gas was 57.5KPa. Injector temperature was of
250◦C and MS ion source and interface temperatures were
230and280◦C,respectively.Themassspectrometerwasused
in TIC mode, and samples were scanned from 40 to 500m/z
units. Compounds thymol, carvacrol, borneol, and linalool
were identiﬁed by comparison with standard mass spectra
obtained in the same conditions and compared with the
massspectrafromlibraryWiley229.Restsofthecompounds
were identiﬁed by comparison with the mass spectra from
Wiley 229 library and by their linear retention index. The
chromatographic method was to be based on the previously
described by Jord´ an et al. [39].
3.1.3. Cell Culture. Human THP-1 monocyte cell lines
(AmericanTypeCultureCollection,ATCC)weremaintained
in suspension in RPMI 1640 culture medium (ATCC)
supplemented with 10% FBS (GIBCO), 100U/mL penicillin
(GIBCO), 100mg/mL streptomycin (GIBCO), 0.05mM β-
mercaptoethanol (Sigma-Aldrich), and 2mM L-glutamine
(GIBCO),atadensityof3–9 ×105 cells/mLat37◦Cin5%air
95% CO2.C e l l sw e r ed i s c a r d e da n dr e p l a c e db yf r o z e ns t o c k s
every 15 passages.
3.1.4. Cell Diﬀerentiation. Cells were pelleted via centrifu-
gation and assessed for viability using the Trypan-blue ex-
clusion method. Viable cells were plated at a density of
5 × 105 cells/mL in 24 wells plates (100μLa n d1 m L ,
resp.) and incubated with Phorbol 12-Myristate, 13-Acetate
(PMA) 100ng/mL (Sigma-Aldrich) for 48h in FBS-free
medium. Afterwards, the wells were washed with PBS and
the treatment initiated.Journal of Obesity 9
3.1.5. Cytotoxicity Assay. Oil extracts toxicity was assessed
using the mitochondrial-respiration-dependent 3-(4,5-dim-
ethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) reduc-
tion method. THP-1 cells were plated in 96-well plates,
diﬀerentiated and incubated with diﬀerent concentrations
of extract for 24 and 48 hours at 37◦Ci n5 %C O 2.A f t e r
treatment, the cells were washed with PBS and incubated
with MTT 1mg/mL in PBS for 2 hours at 37◦Ci n5 %
CO2. Afterwards, formazan crystals produced from MTT
by the mitochondrial hydrolase of the viable cells were
solubilized in lysis buﬀer (10% SDS in 50% dimetilfor-
mamida pH = 7). The absorbance of each well was then
read at 540nm using a microplate reader (Sunrise Remote,
Tecan). The optical density of formazan formed in control
cells (without treatment with extract) was taken as 100%
viability.
3.1.6. Bioactivity Assay. Oil thyme extracts were dissolved
in dimethyl sulfoxide (DMSO; Sigma-Aldrich) to stock con-
centration of 10mg/mL determined as the maximum doses
not cytotoxic by the cell viability assays. THP-1 cells were
diﬀerentiated in 24-well plates. After diﬀerentiation, the cells
were washed with PBS and treated with or without Cu2+
oxidized LDLs to activated or not activated them. Then, cells
wereincubatedwiththecorrespondingthymeextractdiluted
in FBS-free medium, for 24 or 48 hours at 37◦Ci n5 %C O 2.
Afterwards, the supernatant was frozen and RNA isolated.
Aliquots were analyzed to determine secreted cytokines.
3.1.7. Quantiﬁcation of Cytokines. Supernatants were cen-
trifuged at 12,000rpm to remove debris and then stored at
−80◦C until cytokine analysis. IL-10, IL-1β,I L - 6 ,a n dT N F -
α were quantiﬁed using ELISA kits from BD Biosciences,
according to the manufacturer’s instructions. 100μLo f1:1 0
diluted medium was added to anticytokine antibody-coated
polystyrene wells and incubated for 2h. After washing, the
plates were incubated with biotin-labeled secondary anti-
body for 1 hour. The plates were washed and incubated for
30min in the dark with substrate solution. Stop solution was
added and the absorbance read at 450nm with λ correction
at 570nm using a microplate reader (Sunrise Remote, Tecan
Austria GmbH, Gr¨ odig, Austria).
3.1.8. Total RNA Isolation. Total RNA from THP-1 cells was
isolatedusingtheTrizolreagentfromInvitrogen.5×105 cells
were homogenized in 200μL of Trizol reagent and, if neces-
sary, stored at −80◦C. Following homogenization, samples
were left to rest at room temperature for 5 minutes. After
40μL of chloroform was added, the tubes were vigorously
shaken for 15 seconds and let rest at room temperature for
5 minutes. Tubes were then centrifuged at 12000g, 4◦Cf o r
15 minutes. The aqueous (upper and colorless) phase was
transferred to a new tube. 100μL of isopropyl alcohol was
added to the aqueous phase; the tube was then gently mixed
and incubated at room temperature for 10 minutes. After
incubation, samples were centrifuged at 12000g, 4◦Cf o r
10 minutes. A gel-like pellet was formed and the isopropyl
alcohol was removed. The pellet was washed with 200mL of
75% Ethanol in DEPC-treated H2O and centrifuged at 7600,
4◦C for 5min. The ethanol was then removed and the pellet
was let dry until colorless. Total RNA was then dissolved in
15μLo fD E P CH 2O, incubated at 55◦C for 10 minutes, and
stored at −80◦Cf o rf u t u r eu s e .
3.1.9. Gene Expression Quantiﬁcation. Total RNA isolated
from THP-1 cells was quantiﬁcation of IL-1β,I L - 6 ,I L -
10, TNF-α, 18sRNA, and GAPDH gene expression using
real-time PCR. 10ng/μL total RNA was used as template
for cDNA synthesis using the High-Capacity Archive Kit
from Applied Biosystems, according to the manufacturer’s
instructions. Real-time PCR was performed using Taqman
Probes (Applied Biosystems) following the manufacturer’s
recommendations in an AB7900 HT Fast Real-Time PCR
system (Applied Biosystems). The Taqman probes used
were Hs99999029 m1 for IL-1β, Hs00174131 m1 for IL-
6, Hs999999035 m1 for IL-10, Hs00174128 m1 for TNF-
α, Hs99999901 s1 for 18S rRNA, and Hs99999905 m1 for
GAPDH. Gene expression quantiﬁcation was determined
using delta-delta CT method with correction for values
of ampliﬁcation eﬃciency and normalized to 18S rRNA
expression. SDS 2.2.2 software was used. Comparison with
GAPDH as endogenous worked out similar results (data not
shown).
3.1.10. Statistical Analysis. All data were expressed as the
mean ± SEM. For single variable comparisons, Student’s t-
test was used. For multiple variable comparisons, data were
analyzed by one-way analysis of variance (ANOVA) followed
by Dunnett’s multiple comparison test and Bonferroni test
whennecessaryusingtheGraphPadPrismstatisticalsoftware
(GraphPad Software Inc. Windows Version 5). P values less
than 0.05 were considered signiﬁcant.
Abbreviations
oxLDLs: Oxidized low-density lipoproteins
TNF: Tumor necrosis factor.
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